Skip to main content
. Author manuscript; available in PMC: 2014 Dec 30.
Published in final edited form as: Circulation. 2009 Jan 12;119(3):445–451. doi: 10.1161/CIRCULATIONAHA.108.775221

Table 3.

Baseline and follow-up (a) qualitative echocardiographic measures and (b) quantitative MRI indices.

Baseline Last p



a. Echo #, % #, %
 RV Dysfunction (n = 40) 0.03
  None 11 (27.5) 15 (37.5)
  Mild 16 (39.0) 19 (47.5)
  Moderate 9 (22.5) 2 (5.0)
  Severe 4 (10.0) 4 (10.0)
  Median mild mild
 LV Dysfunction (n = 57) 0.37
  None 43 (75.4) 41 (71.9)
  Mild 13 (22.8) 11 (19.3)
  Moderate 1 (1.8) 3 (5.3)
  Severe 0 (0.0) 2 (3.5)
  Median none none
 RV Dilation (n = 27) <0.001
  None 0 (0.0) 6 (22.2)
  Mild 3 (11.1) 11 (40.7)
  Moderate 11 (40.7) 6 (22.2)
  Severe 13 (48.2) 4 (14.8)
  Median moderate mild
b. MRI
 RV EF % (n = 36)
  Mean 46 (9) 45 (12) 0.34
  Median 46 (20-67) 46 (15-68)
 LV EF % (n = 34)
  Mean 60 (8) 57 (9) 0.04
  Median 61 (44-76) 57 (18-70)
 PR % (n = 20)
  Mean 51 (13) 7 (9) <0.001
  Median 50 (25-75) 4 (0-37)
 RVEDVi (n = 35)
  Mean 194 (71) 131 (45) <0.001
  Median 177 (77-424) 124 (56-308)